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Background: Since the 1990s, increasing research has been devoted to the identification of biomarkers for autism to
help attain more objective diagnosis; enable early prediction of prognosis; and guide individualized intervention
options. Early studies focused on the identification of genetic variants associated with autism, but more recently,
research has expanded to investigate neurodevelopmental markers. While ethicists have extensively discussed issues
around advances in autism genomics, much less ethical scrutiny has focused on research on early neurodevelop-
ment and on the interventions being developed as a result. Objectives: We summarize the current state of the
science on the identification of early markers for autism and its potential clinical applications, before providing an
overview of the ethical issues arising from increasing understanding of children’s neurodevelopment in very early life.
Results: Advances in the understanding of brain and behavioral trajectories preceding later autism diagnosis raise
ethical concerns around three themes: (a) New models for understanding autism; (b) Risks and benefits of early
identification and intervention; and (c) Communication of early concerns to families. These ethical issues should be
further investigated in research conducted in partnership with autistic people and their families. Conclusions: This
paper highlights the need for ethical scrutiny of early neurodevelopmental research in autism. Scrutiny requires
expertise and methods from the basic sciences and bioethics, as well as constructive collaborations among autistic
people, their parents, and autism researchers to anticipate early interventions that serve the community’s interests
and accommodate the varied experiences and preferences of people on the spectrum and their families. Keywords:
Autism; biomarkers; genetics; neurodevelopment; infant siblings; ethics.
Introduction
Autism can be viewed as a neurodevelopmental
condition characterized by difficulties in social com-
munication, patterns of restricted and repetitive
behavior, and sensory anomalies (American Psychi-
atric Association, 2013); and/or as a fundamental
part of someone’s identity that comes with strengths
and weaknesses and is part of the spectrum of
human neurodiversity (Kapp, 2020). Diagnosis of
autism occurs in ~1%–2% of children, and diagnosed
children commonly have cooccurring mental health
and medical conditions. In many, but not all diag-
nosed cases, autism emerges in the early years (Lord
et al., 2020). Since the 1990s, research has increas-
ingly focused on the identification of biomarkers for
autism. Biomarkers are measurable indicators of a
biological state and they could be used to supple-
ment an autism diagnosis based on behavioral
criteria; indicate an individual’s increased likelihood
of developing autism; identify individuals developing
autism before they manifest clear observable traits;
and provide indications for targeted treatments
(Yusuf & Elsabbagh, 2015). While early studies
focused on the potential for genetic biomarkers,
research has more recently expanded to investigate
other markers of neurodevelopment.
Neurodevelopmental markers are measures of
infant brain or cognitive function that can be cap-
tured with non-invasive techniques like electroen-
cephalography, eyetracking, or near infra-red
spectroscopy and may predict the emergence of later
autism or co-occurring traits. Neurodevelopmental
markers may be closer than genetic markers to the
final common pathway to autism symptoms, if
autism is seen as an unfolding developmental pro-
cess; and they might offer more information about
both potential later outcomes on that process and
the mechanisms through which developmental
changes will occur, hence providing insights into
how to support a child’s development.
Efforts to identify genetic and neurodevelopmental
markers for autism (the latter termed ‘early autism
research’ in this paper) are usually framed around
supporting development to optimize outcomes. This
framing raises critical ethical questions, not least
because ‘optimal outcome’ has been defined in
various (at times conflicting) ways in the autism
literature and within the autism community.1.
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Definitions have included ceasing to meet autism
diagnostic criteria at some point during develop-
ment; preventing autism in infants with enhanced
likelihood for autism; and developing skills (e.g.
independence, making friends) that the individual
and their family consider meaningful and desirable
(Georgiades & Kasari, 2018).
Bioethicists and social scientists have extensively
discussed ethical issues around advances in autism
genomics in a body of literature known as ‘gen-
ethics’ (see Hens, Peeters, & Dierickx, 2016). Empir-
ical studies have been conducted to investigate the
autism community’s attitudes toward tests to iden-
tify the genetic etiology of an individual’s autism
diagnosis (e.g. Reiff et al., 2015; Wagner et al., 2020),
although this body of literature has important lim-
itations (Yusuf & Elsabbagh, 2015), particularly an
almost exclusive focus on parents’ attitudes, as
compared with the views of autistic people (although
these are not mutually exclusive categories). Much
less ethics scrutiny has been given to research
efforts on early brain and cognitive development in
the autism field and on the interventions being
developed as a result. A few studies have investi-
gated the autism community’s perspectives in this
area (MacDuffie et al., 2020), and issues concerning
research priority setting (see Fletcher-Watson et al.,
2017). This is an important gap because both similar
and distinct ethical concerns to those related to
autism genomic information may arise from increas-
ing understanding of children’s neurodevelopment in
very early life.
In this paper, we begin by summarizing the
current state of the science on the identification of
biomarkers (both genetic and neurodevelopmental)
for autism, and its clinical applications. We then
provide an overview of the ethical issues arising from
the identification of neurodevelopmental markers for
autism, before making recommendations on how
early autism research should be reshaped in focus
and methods to address these concerns.
Research on autism biomarkers
Advances in autism genomics
Estimated at 50%–80%, the high heritability of
autism indicates that a substantial proportion of
variation in autistic symptoms is genetic (Tick et al.,
2016). About 20%–30% of cases of autism can be
linked to rare genetic variants (often duplications/
deletions) that have profound effects on development
and can raise the likelihood of developing autism up
to 40-fold (Dias & Walsh, 2020); some are associated
with particular syndromes (e.g. Fragile X, tuberous
sclerosis). The remaining majority of cases are asso-
ciated with the accumulated effects of many thou-
sands of common variations (Grove et al., 2019), and
can be studied through polygenic ‘scores’, which
summarize an individual’s autism-associated
variants to operationalize individual genetic ‘load’.
Thus, different genetic profiles associate with aut-
ism. However, rare and common variants interact in
complex ways with each other and with environmen-
tal factors, and understanding of these interactions
is currently limited.
Neurobiological mechanisms and early brain
development
Genetic alterations associated with autism provide
insight into the neurobiological mechanisms that
underpin the condition. Such work suggests impor-
tant roles for synaptic function, activity-dependent
transcription and translation, and neuroinflamma-
tion (de La Torre-Ubieta, Won, Stein, & Geschwind,
2016). These processes operate across the brain and
do not readily map onto the specific regions or
processes common to early ‘core deficit’ accounts of
autism, such as the theory of mind account (Baron-
Cohen, Leslie, & Frith, 1985), the weak central
coherence account (Happe & Frith, 2006), and the
social motivation hypothesis (Clements et al., 2018).
While the peak profiles of expression of these genes
occur in prenatal or very early postnatal develop-
ment (see Parikshak et al., 2013), pinpointing this
stage of development as a critical time window, overt
behavioral autism symptoms generally do not
appear until the end of the first year or later; parents
typically express concerns around 16–18 months
postnatal. To better understand how these alter-
ations in early neurobiology contribute to autism,
trajectories of brain development must be studied
from early in infancy before behavioral symptoms
emerge, as autistic people later experience many
secondary difficulties (e.g. anxiety, depression, bul-
lying, isolation) that have their own impacts on brain
function, likely masking the causal processes that
initially triggered early behavioral symptoms (John-
son, Charman, Pickles, & Jones, 2021).
Prospective longitudinal studies of infants with an
elevated likelihood of developing autism allow us to
map the very early changes in brain and cognitive
development that precede the emergence of diagnos-
tic symptoms (Wolff & Piven, 2020). The most
common design is to study infants with an older
sibling with autism (‘infant sibs’), who have about
20% chance of meeting autism criteria at age 3
(Ozonoff et al., 2011), and 20% chance of related
developmental difficulties (Messinger et al., 2013).
Infants are recruited prenatally or in early infancy
and assessed at several timepoints until they reach
age 2–3 years, when a multidimensional assessment
characterizes their developmental outcome. Data on
early development can be linked to later dimensional
and diagnostic outcomes. More recently, such stud-
ies have expanded to include infants with genetic
syndromes linked to higher autism rates (e.g. tuber-
ous sclerosis, McDonald & Jeste, 2021) and infants
with a family history of ADHD (Miller et al., 2020),
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and have incorporated information about polygenic
scores and their association to early neurodevelop-
ment (Gui et al., 2020). Longer-term follow-up of
such cohorts into school age have begun, with a
focus on later-emerging common cooccurring condi-
tions (e.g. ADHD and anxiety, Shephard et al., 2019).
Thus, this field investigates how familial and genetic
factors are translated into an autism diagnosis
through early brain development.
Emergence of social and non-social changes
Prospective studies have not supported initial ideas
that infants with later autism would show profound
social differences from early in infancy. Rather, 6-
month-old infants with later autism look similar on
vocalizations and attention to faces (Ozonoff et al.,
2010), and interest in eyes (Jones & Klin, 2013) to
those with a neurotypical outcome. Over the follow-
ing 2 years, infants with later autism show a gradual
decline in looking to faces and eyes (Gangi et al.,
2020). Proposed explanations for this include mea-
surement error (e.g. challenges in identifying mani-
festations of social difficulties in young infants, as
they have limited social capabilities); a ubiquitous
regression-like profile, only recognized by parents of
children with particularly precocious early skills
(Ozonoff & Iosif, 2019); or a failure to shift from
subcortical to cortically mediated social attention
(Klin, Shultz, & Jones, 2015).
Restricted and repetitive behaviors emerge on a
similar timescale, first becoming measurable around
12 months, although earlier developmental manifes-
tations may have yet to be identified (Ozonoff et al.,
2011). Indeed, neural changes appear early in both
social and non-social domains (e.g. Lloyd-Fox et al.,
2018), suggesting that from its earliest emergence,
autism is associated with subtle differences across
multiple domains of brain development. Initial
machine-learning approaches to predicting autism
from infant data highlight widespread alterations in
cortical thickness (Hazlett et al., 2017), functional
brain activity across a range of scalp regions and
frequency bands (Gabard-Durnam et al., 2019), and
alterations to both social and non-social stimulus-
locked processing (Tye et al., 2020). This evidence
makes it implausible that a single brain ‘deficit’
solely responsible for the development of autism will
emerge.
Clinical applications of early autism research
Predicting emergence and outcomes
Although work on the early development of autism
has yielded important insights, translation to clinical
practice has only just begun. With regard to poten-
tial for early identification, some infants begin to
display behaviors consistent with a diagnosis from
12 months (Pierce et al., 2019), but many others will
not show a clear enough pattern of symptoms until
age 2 or later (Ozonoff et al., 2015). Even within
prospectively assessed cohorts overseen by experi-
enced clinicians, some children considered to have
autism in mid-childhood did not meet autism criteria
at age 3 (Ozonoff et al., 2018), which complicates
prediction and hence raises a range of ethical issues
that we discuss below. Further work on the param-
eters yielding reliable individual estimates is neces-
sary, but clinical prediction based on single
measures is unlikely to be successful if autism
represents the accumulation of inherited predispo-
sitions that act additively (Constantino, Charman, &
Jones, 2021) or interactively (Johnson et al., 2021)
to determine outcomes.
In response, some have attempted to identify more
biologically homogeneous ‘subtypes’ of autism (Wol-
fers et al., 2019) that could be associated with
distinct early developmental pathways. It could be
fruitful to align these approaches with the DSM shift
from subgrouping within autism toward subgroup-
ing based on profiles of associated difficulties (e.g.
with/without intellectual disability or language
delay). Indeed, early infant profiles may be more
relevant in predicting constellations of dimensional
traits than categorical diagnoses (e.g. cognitive,
adaptive skills, or autistic traits, Jones et al.,
2020). For example, Hendry et al. (2020) identified
subgroups of infant sibs by their trajectories of
development of attention skills; infants who showed
a profile of plateauing attentional growth between 10
and 25 months were more likely to have elevated
autism and ADHD traits, and lower adaptive func-
tion at 3 years. Longer-term follow-up of such
cohorts is required to determine whether such early
neurodevelopmental profiles make autism more
likely to be diagnosed in early development, rather
than represent a subtype of autism that meaning-
fully persists over developmental time.
The concept and current practice of pre-emptive
intervention
One of the primary stated motivations for identifying
early markers of autism is that very early interven-
tion at the time of greater brain plasticity may be
especially effective (Webb, Jones, Kelly, & Dawson,
2014). This involves a shift from viewing autism as a
categorical state that is determined from birth by
genetic factors, to a polygenic and multifactorial
condition with a spectrum of possible presentations
whose symptoms result from an atypical develop-
mental path that could be targeted with early inter-
vention. As such, some have proposed that early
interventions could prevent or ameliorate the emer-
gence of the disabilities associated with autistic
traits if successful (Klin et al., 2020). Traditional
biomedical perspectives couched this as a
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‘preventative approach’, although nowadays a more
acceptable concept is that of ‘pre-emptive interven-
tions’ (Insel, 2007). Under our definition the latter
are early and prodromal interventions, initiated
before the full expression of a condition, that seek
to mitigate developmental risk and optimize out-
comes. This can include both approaches seeking to
ameliorate the emerging onset of manifestations
(early symptoms) of autism (closer to the traditional
‘prevention’ notion); and approaches enhancing and
supporting compensatory factors or alternative
developmental pathways that promote broader
developmental competencies and outcomes, which
differ from, but may interact with, the unfolding
expression of autism traits or symptoms in the
individual (closer to a ‘skills’ rather than a ‘deficit’
approach).
Observational research with infant siblings can
provide two important classes of insight to designing
early intervention programs. First, information
about the nature and timing of early developmental
delays can inform the design of intervention pro-
grams that target the classes of early emerging
symptoms that are manifested in delayed, or atypical
onset of, typical developmental skills. The second,
and perhaps more fruitful, avenue is to investigate
protective or compensatory factors in early develop-
ment that can be targeted with supportive interven-
tions. This includes supporting interactions between
infants and their parents (Wan, Green, & Scott,
2019); or targeting modifying factors (like effortful
control/executive functioning) that can interact with
earlier neurodevelopmental changes to shape trajec-
tories in a typical or atypical direction (Johnson
et al., 2021). Therapies that aim to strengthen these
modifying factors (e.g. executive function skills)
could act to buffer development toward an optimal
outcome for the child.
The first wave of early intervention studies
A range of parent-mediated interventions have been
trialed in infants in the autism context to enhance
aspects of social engagement and attention via
‘environmental enrichment’. These focus on enhanc-
ing parent-child dyadic communication and engage-
ment (Landa, 2018), but may also increase caregiver
knowledge and empowerment and may reduce
parental stress. Interventions in infancy are some-
times applied in a ‘selective’ manner to individuals at
elevated likelihood of a condition (e.g. infants with a
family history of autism), with a focus on general
enrichment to mitigate early emerging atypicalities.
Alternatively, they have been applied in an ‘indi-
cated’ manner in infants showing very early signs of
a condition (e.g. via a screen), with a focus on these
emerging symptoms even if they are not yet well
established (Green, 2019). For example, Green and
colleagues adapted the parent-mediated Video Inter-
action to Promote Positive Parenting (VIPP) program
and tested its preliminary efficacy in a 12-week pilot
randomized controlled trial (RCT) with 10-month-old
infants at elevated familial likelihood of autism. At
14 months the intervention group showed increases
in parental non-directiveness and infant attentive-
ness to parent (Green et al., 2015), and at 36 month
follow-up an overall reduction in autism traits as
measured over time with Autism Observation Scale
for Infants (AOSI) and the Autism Diagnostic Obser-
vation Schedule (ADOS) (Green et al., 2017). There
were no differences on standardized measures of
developmental, language, or communication skills.
Two recent RCTs using an ‘indicated’ design with 12-
month-old infants identified via screening are White-
house et al. (2019), which reported no differences in
parenting behavior or in child dyadic communica-
tion; and Watson et al. (2017), which reported
increases in parental responsiveness but no changes
in infant adaptive functioning or language. Neither of
these studies reported amelioration of early autism
traits postintervention, although both have yet to
report on longer-term outcomes.
Two crucial challenges arise from early identifica-
tion and intervention studies. First, definition of the
appropriate target of prediction and intervention,
which requires a judgment as to the most important
developmental outcomes for children. Second, deci-
sion about who should make this judgment. As we
discuss below, early autism research gives rise to
potentially conflicting rights, priorities, and interests
among children, parents, and autistic adults. In the
few intervention trials conducted to date, the pri-
mary and secondary outcomes are often a combina-
tion of proximal developmental ‘precursors’ of later
developmental outcomes (e.g. infant attentiveness),
more distal developmental outcomes (e.g. language
and communication skills), but also measures of
early emerging autism symptoms such as the AOSI
and the ADOS. It should be noted that early emerg-
ing symptoms seem to predict later cooccurring
conditions (e.g. anxiety), whose treatment is high
among autistic adults’ priorities (Leadbitter, Buckle,
Ellis, & Dekker, 2021). However, the appropriate
outcomes to measure in early pre-emptive interven-
tion studies may be broader than a reduction in
autism traits or symptoms (Kasari, 2019), as these
are not present (or not fully substantiated) in the first
12–18 months of life, and intermediate phenotypes
at this stage are likely shared between children with
later autism and those who will have other neurode-
velopmental conditions (Constantino et al., 2021).
From a clinical perspective, an approach targeted
toward a wider array of developmental competencies
that share commonalities with, but are in part
distinct from, early autism signs is warranted.
Indeed, many young children with broader early
emerging neurodevelopmental difficulties struggle to
communicate and interact with others; this restricts
their opportunities to learn and develop, and affects
their parents, who can find their child’s behavior
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challenging (Charman, 2019). Additional early neu-
rodevelopmental phenotypes shared by infants who
may later develop autism or other neurodevelopmen-
tal conditions (e.g. difficulties in early executive
attention) might also be amendable to interventions
that act trans-diagnostically, and potentially have
effects on the later emergence of common co-
occurring traits (Talbott & Miller, 2020). Thus,
selecting appropriate outcome measures in early
intervention studies will require deep knowledge of
developmental cascades, in addition to an integra-
tion of the perspectives of all those involved. Below
we show that, despite the laudable goals of early
interventions seeking to optimize children’s out-
comes, our increasing understanding of children’s
neurodevelopment in very early life raises a number
of ethical challenges.
Overview of the ethical issues
Early identification and intervention in the context
of autism pose significant challenges to three
premises of ethically robust clinical interventions:
we know what to intervene on; we can reliably
assess benefits and harms; and we have good
reasons to intervene (Singh, 2016). We present
such challenges as organized around the following
themes: (a) New models for understanding autism;
(b) Risk and benefits of early identification and
intervention; and (c) Communicating early concerns
to families.
New models for understanding autism: What could
and should we intervene upon?
Research into early neurodevelopment has led to
new models for conceptualizing autism, with impli-
cations for what could and should be targeted in
early life. Increasing recognition of the role of
heterogeneity and the lack of clear biological and
genetic boundaries among different neurodevelop-
mental conditions, has inspired a shift from the
categorical focus more typical of diagnostic manuals
like the DSM, to dimensional and other stratification
approaches like RDoC or ESSENCE (see Gillberg &
Fernell, 2014). The application of these models in
autism aligns with increasing acknowledgment of
the dimensionality of psychiatric conditions more
broadly (Kong & Singh, 2018), and could allow
interventions to be more precisely targeted to partic-
ular symptom dimensions (like communication
problems). However, in clinical setting, psychiatric
diagnoses have an important pragmatic and social
function (e.g. for access to relevant support and
services for individuals and families). Moreover,
shifting to a purely dimensional view might impact
the identity and sense of self of people diagnosed
with autism. Emerging evidence among people pre-
viously diagnosed with Asperger’s, who identified
with their diagnosis and did not see it as
interchangeable with the autism label, suggests that
the integration of the Asperger’s diagnosis into the
broader ‘autism spectrum disorder’ diagnosis in
DSM-5 has had negative impacts on dimensions of
self-understanding (Smith & Jones, 2020).
The trend toward dimensional approaches and
recognition of substantial biological heterogeneity in
the broader field has begun to influence prospective
studies of autism emergence. Although often impli-
cit, two conceptual stances can be detected. The first
(simpler) view is that dimensional variation in infant
phenotypes will map onto dimensional variation in
domain-relevant later strengths and difficulties,
particularly in the area of conditions commonly
associated with autism. For example, dynamic mod-
ulation of frontal theta EEG predicts later variation
in core cognitive skills (Jones et al., 2020); early
infant fearfulness predicts later anxiety; early
heightened activity level predicts later ADHD symp-
toms (Shephard et al., 2019); and infant over-
connectivity in the alpha oscillatory EEG band
relates to later restricted interests (Haartsen, Jones,
Orekhova, Charman, & Johnson, 2019). These
insights do raise the possibility that infant interven-
tions could be targeted to particular domains of
difficulty that are considered a priority for the
autistic community, although currently these pat-
terns are correlational, and causality should not be
assumed.
An alternative (or complementary) view is that a
separable set of inherited predispositions sum to
trigger the emergence of the behavioral symptom
clusters that we label as autism (Constantino et al.,
2021). This may operate through a whole-brain
process in which behavioral traits like repetitive
behavior or social withdrawal represent adaptive
reactions to a brain that processes the environment
differently (Johnson et al., 2021); or represent the
consequences of a lack of necessary early experi-
ences (Klin et al., 2020). In both models, interven-
tions that alter the degree to which an infant
experiences these early dimensional traits could
impact the likelihood of emergence of later autistic
behaviors. However, dimensional variation in the
infant predictors of later autism is not necessarily
hypothesized to map simply and predictably onto
dimensional autistic trait variation in later develop-
ment, because of the intermediate operation of
whole-brain or stochastic processes (Constantino
et al., 2021). Thus, it should not be assumed that
interventions targeted at particular processes in
early infancy would translate in a simple way to
predictable shifts in later phenotypes.
Models that view the behavioral traits associated
with autism not as maladaptive, but as the result of
an alternative developmental pathway, or as an
adaptive response to a brain that processes infor-
mation in a different way (Johnson, 2017; Johnson,
Jones, & Gliga, 2015), accommodate the idea that
variation between individuals is a critical part of our
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
Child and Adolescent Mental Health.
Ethics of translational neurodevelopmental research in autism 5
adaptive success as a species. This viewpoint is often
obscured by biomedical models that focus on indi-
vidual ‘impairments’ and ‘deficits’ relative to typical
development. The ‘deficit’ language, and so assump-
tions that any difference in an autistic child must be
‘worse’, makes it difficult to assume ability, poten-
tial, and advantageous traits in autistic children.
Defining neurodevelopmental diversity by its disad-
vantageous elements or core deficits might also
preclude the development of interventions whose
delivery and success depend on those advantageous
traits (Astle & Fletcher-Watson, 2020).
Although this line of thinking is familiar in autism
studies, and resonates with the claims of the neuro-
diversity movement (Kapp, 2020), we argue that
adaptive models of autism raise important questions
about the feasibility and desirability of the early
intervention agenda, which in the existing literature
have only been discussed to a limited extent (e.g.
Mottron, 2017), and have not been fully addressed in
current research practice. First, if autism is the
result of the (additive or interactive) accumulation of
a range of separate predispositions, early neurode-
velopmental markers may not look like later features
of autism (Johnson, 2017). This challenges the
assumption that we know what we could intervene
upon in early infancy, because at this stage the
structure of autism could present differently from
the autism symptoms that are consolidated in early
childhood behavior. Moreover, if autism ‘symptoms’
are in fact the result of necessary adjustments or
responses to an atypical starting state, intervening
early on these ‘symptoms’ might have negative
implications on other functions they compensate
for. This raises the question whether we should
intervene early in the development of autism in the
first place, or at least makes it ethically compelling to
carefully consider the degree to which we under-
stand the system in which we are intervening.
However, if we view some of the dimensional traits
that lead to autism as making it difficult for a child to
learn from the typical environments provided to
infants and young children (Klin et al., 2020), it
may also be unethical not to provide an environment
in which autistic children can learn.
Early identification and interventions: Can we
properly weigh risks and benefits for all those
involved?
One fundamental challenge of early autism research
is that our current ability to predict later autism is
(and may remain) probabilistic given the interaction
of multiple genetic and environmental factors in
shaping trajectories. With any probabilistic outcome,
attempts at early prediction may lead to false posi-
tives; this can trigger a range of unnecessary surveil-
lance strategies (Wolff & Piven, 2020). Conversely,
because early in life infants with later autism show
behavioral traits that are similar to those of typically
developing children, risk of false negatives should
not be underestimated, especially considering that
parents have highlighted the long time lag between
first concerns about their child’s development and
their age of diagnosis (Szatmari et al., 2016). Fur-
thermore, some have questioned the generalizability
of behavioral signs identified in infant sibling design
studies (Szatmari et al., 2016), which echoes broader
discussions about the appropriateness of universal
early screening versus screening of symptomatic
children (Graf, Miller, Epstein, & Rapin, 2017).
Within such a high level of uncertainty, it is
difficult to make reliable individual assessments of
risks and benefits of early identification and inter-
vention. One option could be to conduct more
research to better corroborate early neurodevelop-
mental markers for individual prediction of categor-
ical autism, so that interventions that are designed
to be appropriate for children with autism are not
widely applied. At a minimum, these interventions
should avoid repeating the history of adopting
painful aversives to treat autism, and oppose the
current trend of poor monitoring and reporting of
adverse events in research on psychosocial interven-
tions for autism (Bottema-Beutel, Crowley, Sand-
bank, & Woynaroski, 2020). However, the
probabilistic nature of predictions means that in
early autism research there will always be children
who will grow up following a neurotypical profile.
Thus, it would also be important to develop inter-
ventions targeted to domains of relevance to all
children—such as language abilities—to ensure a
positive benefit/harm ratio for any child.
It is important to note that uncertainty is not
confined to our capacity to predict whether an infant
will later develop autism or not; it also extends to our
capacity to predict autistic people’s future outcomes
from childhood data. While we have stronger confi-
dence in early predictors such as language develop-
ment, prediction of global outcomes increases
through to age 9 years (Pickles, McCauley, Pepa,
Huerta, & Lord, 2020); and for outcomes such as
mental health, prediction is only possible with data
collected in adolescence, or it is not possible at all
(Forbes, Lord, Elias, & Pickles, 2021). Acknowledg-
ing that very early development influences, rather
than determines, autistic individuals’ future out-
comes is fundamental to oppose certain assump-
tions that may (and do) harm children and their
parents. Among these is the assumption that, past
2–3 years of age, it is too late to intervene in a child’s
development, which puts excessive pressure on
parents to do anything possible during their chil-
dren’s first few years, and may lead some to argue
more strongly for and justify dangerous therapies
(e.g. chelation, James, Stevenson, Silove, & Wil-
liams, 2015) for children beyond that age. In turn,
this has nurtured a research culture which at times
allows unnecessarily invasive, painful, and distress-
ing procedures to be performed on young autistic
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children for the sake of identifying biomarkers for
autism (e.g. Pardo et al., 2017); and which places
undue emphasis on early intervention at the expense
of ensuring support to autistic people throughout
the life span.
These considerations highlight the importance of
assessing risks and benefits of early identification
and intervention from different perspectives, by
consulting with autistic people, across childhood
and into adulthood, as well as their parents. Indeed,
early autism research gives rise to two competing
ethical principles. On the one hand, there is parents’
right to know about their children’s susceptibility to
neurodevelopmental conditions, and their right to
intervene on such susceptibility, to act in the best
interests of the child or the family more broadly.
Parents’ views are central to discussions around pre-
emptive interventions, as these involve very young
children. On the other hand, some scholarship on
corrective or enhancing interventions on children
has argued that a child’s ‘right to an open future’
should be respected (Feinberg, 1992). One might
argue that ‘right to an open future’ has limited teeth,
given that children are inevitably and necessarily the
subject of their parents’ influences and interventions
from the start. However, the spirit of the ‘open
future’ principle is useful when judging which
actions of parents might violate ‘best interests’ at a
stage when children are wholly dependent on their
parents to shape their developmental trajectories.
Labeling a child early in life as ‘at risk’ of neurode-
velopmental challenges, and so as in need of
increased surveillance could lead parents and the
wider society to treat the child as someone who will
eventually develop autism (MacDuffie, Estes, Peay,
Pruett, & Wilfond, 2021). Thus, stigmatizing atti-
tudes could be directed toward the child, due to the
negative assumptions people often hold about aut-
ism. Moreover, autistic adults have criticized certain
early interventions, envisioned to make autistic
children indistinguishable from their peers, as being
motivated by a ‘normalization’ agenda (e.g. Applied
Behavioural Analysis, Ne’eman, 2010). The ‘right to
an open future’ ideal does not exclude the possibility
that interventions can be compatible with neurodi-
versity interests (Leadbitter et al., 2021). Rather, it
calls on us to judge the rightness of interventions on
a very young child against a wider range of potential
good outcomes for that child, one of which is
establishing an authentic sense of self, and flour-
ishing with autism.
Communicating early concerns about a child’s
development to their families: Are concerns widely
shared?
In studies of infants with a family history of autism,
specific harms might derive from communicating
early concerns about a child’s development to
parents. With neurodevelopmental markers that
remain probabilistic, and in the context of trials that
do not always offer an intervention component,
raising concerns is recognized as problematic (Mac-
Duffie et al., 2021). It could harm parents, by
(perhaps unnecessarily) increasing their anxiety
during a period of uncertainty about their child’s
future or removing hope about their child’s develop-
ment.
A related, but less discussed, issue is whether
atypical development should be a matter of concern
in the first place. A variety of views exist on the
value judgments that should be attached to autism,
and the proposition that flourishing with autism is
both reasonable and desirable is an important
motivation for the neurodiversity movement and
its allies (Kapp, Gillespie-Lynch, Sherman, & Hut-
man, 2013). Thus, not everyone in the autism
community agrees with certain understandings of
‘optimal’ development that underpin early interven-
tion approaches, particularly those that aim at
preventing a diagnosis later in life, and so with
the premise that we have good reasons to intervene
early in the development of autism to slow down or
stop its progress. Some instead favor research that
would shed light on the unique development of
autistic individuals (Fletcher-Watson et al., 2017).
This may be particularly the case in families
enrolled in early intervention trials, who likely have
enhanced rates of autism traits or diagnosis,
including in the parents themselves (MacDuffie
et al., 2020), and so may be against pathologizing
autism.
Moreover, some of the early intervention literature
seems to be grounded on implicit normative
assumptions on what being a good parent means
(Mortimer, McKeown, & Singh, 2018). Effective
parent-mediated interventions require an under-
standing of what aspects of parenting behavior are
relevant for optimal neurodevelopment, in addition
to agreement on the definition of ‘optimal. ’ Because
parenting interventions involve discussions about
the influence of parents’ behaviors on their infants’
developmental progress, framing such progress as
concerning may be offensive to families who have
accepted autism as part of their identity and their
family bond. At the same time, early intervention
research and programs might nurture parents’ self-
blame for having caused the difficulties their chil-
dren experience, particularly given the burden of
historical accusations, such as the ‘refrigerator
mother’ (Bettelheim, 1967). Early autism research-
ers should continue to be aware of how their
research could (even if unintentionally) shape con-
ceptions of the good life, good parenting, and good
developmental outcomes. Researchers should be
supported to anticipate and manage such conse-
quences in their research and in respectful engage-
ments with families.
© 2021 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for
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Reshaping early autism research
The above discussion shows that important ethical
concerns emerge from research on early neurodevel-
opment in the autism field, and from psychosocial
interventions being developed as a result of this
research. We propose several recommendations to
address these concerns.
First, efforts to identify early neurodevelopmental
markers for autism should go together with research
investigating autistic people’s attitudes toward new
emerging models of autism. In addition, studies
should address ethical considerations such as
authenticity, flourishing, blame, responsibility, and
interests, among parents of autistic children enrolled
in early intervention studies. Investigations should
also address how older autistic siblings perceive
efforts to intervene early in the development of
autism in their younger siblings, and possible impli-
cations on their self-understanding. Such research
will be methodologically challenging, particularly
given the range of capabilities of autistic children.
However, recent methodological advances indicate
the potential for eliciting first-person perspectives of
autistic young people with minimal verbal abilities
(Tesfaye et al., 2019). Finally, longer-term follow-up
of cohorts of infant siblings into school age have
begun, and it is reasonable to posit a research
agenda that investigates the attitudes and first-
person experiences of early and pre-emptive inter-
ventions among these children. Case studies of
families could address ethical questions around the
impact of such experiences on younger siblings’ self-
perceptions, and on their relationship with their
older autistic siblings.
For these themes to be addressed in future
studies, early autism research cannot be confined
to laboratory work; rather, cross-disciplinary col-
laborations adopting methods from the basic
sciences and the humanities and social sciences
are needed. Because we were only able to offer an
overview of some of the emerging ethical issues,
bioethicists should further interrogate the empirical
dimensions of the ethical challenges identified here,
as well as identify any gaps in our analysis.
Alongside this empirical work, it is also important
to conduct further normative assessment of the
potential harms and benefits of early identification
and intervention, to better inform researchers,
parents, and policy makers. Autism research is
both a model for, and a lesson in, the importance of
conducting research with members of a community
bound together by a common set of psychiatric or
developmental labels. Methods that enable inclu-
sion of the neurodevelopmentally, politically, and
demographically diverse range of autistic children
and adults are particularly important to develop
and implement.
Concluding remarks
Our aim was to summarize the ethical issues
emerging from new research on the identification of
neurodevelopmental markers for autism. The great
majority of ethical analysis to date has focused on
genomic markers for autism; however, there are
significant and distinctive ethical considerations for
psychosocial interventions, affecting infants, par-
ents, other family members, and society as a whole.
Our analysis has highlighted the importance of a
two-way dialogue between early autism researchers
and ethicists, to help facilitate research and real-
world applications and psychosocial interventions
that promote flourishing in children, families, and
societies. Such an approach requires expertise and
methods from the basic sciences and bioethics, as
well as constructive collaborations between autistic
people, their parents, and autism researchers.
Together, we can work toward early interventions
that serve the autism community’s interests and
accommodate the varied experiences of people on the
spectrum and their families.
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Key points
 Early autism research has inspired dimensional models of autism, which might impact on the self-
understandings of people diagnosed with autism; and adaptive models, which question the desirability of
intervening upon potentially necessary early responses to a brain that processes information differently.
 Early autism research faces methodological challenges around individual prediction of later autism, which
challenges reliable risk/benefit assessments of early identification and intervention.
 Early intervention into autism raises potential conflicts between parents’ right to know about their children’s
susceptibility to autism and children’s right to an open future.
 Early autism researchers should reflect on whether their research imposes certain conceptions of optimal
developmental outcome and/or good parenting.
 Future research should address ethical considerations such as blame and responsibility among parents;
investigate older autistic children’s attitudes toward early identification and intervention; and explore the
impact of experiences of early interventions on younger siblings.
Note
1. We use the term ‘autism community’ to refer to a
broader group than people with an autism diagnosis
or people who self-identify, and to include their
family members, particularly their parents and sib-
lings, as well as autism researchers.
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